Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes.

Lehmann BD, Pietenpol JA
J Pathol. 2014 232 (2): 142-50

PMID: 24114677 · PMCID: PMC4090031 · DOI:10.1002/path.4280

MeSH Terms (13)

Animals Antineoplastic Agents Biomarkers, Tumor Drug Discovery Female Genetic Predisposition to Disease Humans Molecular Targeted Therapy Patient Selection Phenotype Precision Medicine Signal Transduction Triple Negative Breast Neoplasms

Connections (3)

This publication is referenced by other Labnodes entities: